rs571312 — MC4R MC4R Regulatory Variant (Appetite Signaling)
Regulatory variant upstream of MC4R associated with increased caloric intake, elevated BMI, and obesity risk through reduced MC4R satiety signaling
See your personal result for MC4R
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
The MC4R Appetite Gate — A Third View of the Same Risk Haplotype
The melanocortin-4 receptor (MC4R) is the master satiety switch of the human hypothalamus.
When activated by alpha-melanocyte stimulating hormone (α-MSH), MC4R signals to stop eating
and ramp up energy expenditure. rs571312 sits upstream of the MC4R gene in the same
regulatory block11 regulatory block
a cluster of three variants — rs17782313, rs571312, and rs476828 — that
lie in the distal linkage disequilibrium zone roughly 188 kilobases downstream of MC4R and
collectively modulate its expression as the more extensively studied rs17782313. In
Europeans, rs571312 and rs17782313 are in perfect linkage disequilibrium22 in perfect linkage disequilibrium
r²=1 in HapMap
CEU, meaning the two SNPs are inherited together on the same haplotype block so completely
that knowing one allele predicts the other with 100% accuracy.
Understanding rs571312 fills an important gap: while rs17782313 is the anchor variant in most European GWAS analyses, rs571312 was genotyped independently in key studies — including the Korean Genome Epidemiology Study and the Diabetes Prevention Program — and provides direct evidence linking the MC4R regulatory haplotype to food intake behavior rather than just adiposity outcomes. The A allele is the risk allele, associated with an ~18% increased obesity risk per allele (OR=1.18, 95%CI=1.15–1.21 per Xi et al. meta-analysis) and a documented increase in daily caloric consumption of approximately 60 kilocalories per allele.
The Mechanism
Like its haplotype partners, rs571312 is a non-coding regulatory variant. It does not
change the MC4R protein itself but modulates how much MC4R the hypothalamus produces. The
proposed mechanism mirrors what has been established for rs17782313: the A allele is
associated with increased CpG methylation33 CpG methylation
a chemical tag on DNA that silences gene
expression — here reducing MC4R transcription in hypothalamic neurons at the MC4R
promoter, leading to reduced receptor density in the appetite-regulating circuits of the
arcuate nucleus and paraventricular nucleus. Fewer MC4R receptors means weaker responses
to the leptin → POMC → α-MSH satiety cascade — a biological "deaf ear" to the hormonal
signal that says "you've had enough."
The result is a phenotype characterized not by altered resting metabolic rate, but by
subtly impaired satiety signaling — the brain continues receiving "keep eating" tone
longer than it should after a meal. The Korean Genome Epidemiology Study44 Korean Genome Epidemiology Study
8,830 Korean
adults aged 40–69 with direct analysis of MC4R variants showed
BMI was significantly higher with each additional A allele even after adjusting for age,
sex, residence, energy intake, activity, and smoking. Crucially, this effect was amplified
by mental stress — under high-stress conditions, the BMI difference between A allele
carriers and CC homozygotes widened substantially.
The Evidence
The discovery-level evidence for rs571312 as an obesity risk variant comes from a 2009
childhood obesity study55 2009
childhood obesity study
Grant et al., examining 728 obese and 3,960 normal-weight
European-American children that identified
rs571312 as a perfect surrogate for rs17782313 (r²=1) conferring OR=1.14 for obesity in
European Americans. The variant showed no significant association in African Americans
(r²=0.149 with rs17782313 in that ancestry), a population-specific pattern that underscores
the importance of haplotype architecture for interpreting its effects.
Beyond BMI, rs571312 has a documented behavioral footprint. The Diabetes Prevention
Program analysis66 Diabetes Prevention
Program analysis
examining 3,180 adults at high risk for type 2 diabetes
found that each additional A allele was associated with 61 extra kilocalories consumed
per day (β=61.32, SE=26.24, P=0.019), replicating earlier findings from the Nurses'
Health Study and Scottish cohorts. This positions rs571312 as a caloric intake amplifier
— not dramatically, but persistently, across decades of meals.
The Korean cohort further showed a significant interaction between the MC4R variants and mental stress (p=0.0384): among individuals under high mental stress, A allele carriers had substantially higher BMIs than CC homozygotes, whereas under low-stress conditions the genetic effect was much smaller. This gene-environment interaction explains why stress management has biological, not just psychological, relevance for A allele carriers.
In a Chinese Northern Han study77 Chinese Northern Han study
1,100 participants stratified by metabolic health
status six MC4R-region SNPs including
rs571312 were genotyped across metabolically healthy and unhealthy obese groups. The
strongest signal came from rs2331841, where the AG genotype conferred 82% higher
obesity risk (OR=1.82, P=0.030) and was associated with higher diastolic blood
pressure. While rs571312 was genotyped, the study did not report a significant
independent association for this variant specifically. The broader finding supports
the MC4R region's involvement in metabolically unhealthy obesity88 metabolically unhealthy obesity
obese with at
least two additional cardiometabolic risk factors: elevated blood sugar, blood
pressure, triglycerides, or low HDL-cholesterol through multiple linked variants.
Practical Implications
The caloric intake phenotype is particularly actionable. An extra 61 kcal/day per A allele sounds modest, but sustained over years it can substantially shift body weight trajectory — 61 kcal/day is roughly the caloric content of a small apple, compounding over time. Because the effect appears to operate through chronic caloric overconsumption rather than episodic bingeing, interventions that reduce baseline appetite or improve satiety signaling are well-suited to this variant.
Given the documented stress-MC4R interaction, cortisol-lowering strategies directly reduce the risk conferred by the A allele. Behavioral evidence from rs17782313 studies — which tag the same functional haplotype — shows that emotional eating patterns and binge eating under stress are elevated in MC4R risk allele carriers; the same interventions apply here.
Interactions
rs17782313 and rs12970134: rs571312 is in high LD with rs17782313 (r²=1 in European ancestry), meaning the two variants almost always co-occur on the same chromosome. Their effects are largely shared — rs571312 tags the rs17782313 risk haplotype in populations where these SNPs are genotyped differently. rs12970134 is a third regulatory variant in the same region, tagged by a related but distinct haplotype; it shows a particularly strong signal for waist circumference and insulin resistance, complementing rs571312's caloric intake signal. None of these three variants add independently in carriers who have all three — they are measuring overlapping variance in the same regulatory block.
FTO rs9939609: MC4R and FTO operate through distinct mechanisms (appetite signaling vs. thermogenesis), and their effects on obesity risk combine across the genome. A Chinese pediatric study found that individuals carrying risk genotypes at both loci had 2.45-fold increased obesity risk (OR=2.45, 95%CI=1.12–5.37) compared to carrying neither, with the two pathways providing complementary intervention targets.
Genotype Interpretations
What each possible genotype means for this variant:
Normal MC4R regulatory function — standard caloric intake and appetite signaling
You carry two copies of the C reference allele, associated with typical MC4R regulatory activity and normal satiety signaling. Approximately 58% of people globally (about 59% of European descent) share this genotype. Your hypothalamic melanocortin system responds to leptin and α-MSH at standard sensitivity, and you have no MC4R-haplotype-driven predisposition to elevated caloric intake or stress-amplified appetite at this locus.
One A allele mildly increases caloric intake and obesity risk
The A allele in this MC4R regulatory variant operates through the same haplotype as rs17782313 in European ancestry (r²=1 — they are essentially the same signal). Your AC genotype places you in an intermediate risk category: the biological "stop eating" tone from your hypothalamic melanocortin system is slightly reduced compared to CC homozygotes, but not as diminished as in AA homozygotes.
The key behavioral insight is the stress amplification: under low mental stress, the BMI difference between AC and CC carriers is small. Under high chronic stress, the genetic effect on appetite and body weight becomes meaningfully larger. This makes stress management a mechanistically specific intervention for your genotype, not generic advice.
Two A alleles substantially reduce MC4R satiety signaling, increasing caloric intake, BMI, and cardiometabolic risk
AA homozygotes represent the high-risk tail at this MC4R regulatory locus. The Diabetes Prevention Program documented the intake phenotype most clearly in the full sample; the Korean Genome Epidemiology Study showed the stress-BMI interaction was significant for MC4R risk alleles (p=0.0384), with AA carriers expected to show the largest stress-driven appetite dysregulation. The lack of association in African Americans (r²=0.149 with rs17782313 in that ancestry) means the AA genotype is most predictive in European and Asian ancestry groups — the same haplotype block may not carry the same risk signal in African ancestry due to different LD patterns.
A Chinese Northern Han study of 1,100 participants found the broader MC4R region associated with metabolically unhealthy obesity, with nearby variant rs2331841 reaching significance (OR=1.82, P=0.030) and linking to elevated diastolic blood pressure. While rs571312 was genotyped but did not reach independent significance, its high LD with other MC4R risk variants suggests AA carriers should monitor metabolic markers beyond BMI alone.